Nevertheless, the existing genetic engineering techniques have allowed the creation of FcαRI transgenic mouse models, which have been used to confirm the powerful capacity of IgA-mediated tumor killing by myeloid cells in a few studies for EGFR+ tumors (246, 247). This evidence concerns the gene CD79A and neoplasm.